Etonogestrel Implants Protect Ovarian Reserve Function in Systemic Lupus Erythematosus

Summary

This clinical trial aims to test in female patients with systemic lupus erythematosus (SLE). The main question it seeks to answer is whether etonogestrel implants can protect ovarian reserve function in patients with SLE. Participants will be randomly divided into a test group and a control group. The test group will be implanted subcutaneously with etongestrel for one year. Researchers won't intervene in the control group. After three months of drug-eluting, researchers will compare measures of ovarian reserve function in the test and control groups to see if etonogestrel implants can protect ovarian reserve function in patients with SLE.

Timeline

Start

2023-04-01

Primary completion

2025-10-31

Completion

2025-10-31

Drugs

Indications